When Your AI Doctor Has a Conflict of Interest

Episode 44 of AI Ethics with Fexingo examines a growing concern in healthcare AI: algorithm developers with financial ties to the treatments their models recommend. Lucas and Luna dissect a 2025 study from the Journal of Medical Ethics that found 30 percent of clinical AI tools are co-developed by pharmaceutical companies whose drugs the algorithms prioritize. They explore the case of an AI sepsis-detection system that nudged clinicians toward a specific antibiotic brand, and discuss why the FDA's current clearance process for AI-based software as a medical device doesn't require disclosure of sponsorship. The hosts also touch on how hospital procurement teams rarely check for these conflicts, and what a new bipartisan bill in Congress proposes to require transparency. A concrete look at how financial incentives quietly shape the algorithms that inform your treatment. #AIEthics #HealthcareAI #ConflictOfInterest #MedicalBias #Pharma #SepsisAlgorithm #FDAClearance #AlgorithmicTransparency #ClinicalAI #JournalOfMedicalEthics #Policy #Congress #BipartisanBill #Technology #FexingoBusiness #BusinessPodcast #ResponsibleAI #AI Keep every episode free: buymeacoffee.com/fexingo